litlas
ログインアカウント作成

Jianhua Chen

1990–2026 年に発表

560
論文数
24,655
被引用数
78
h 指数
326
i10 指数

被引用数

Jianhua Chen の年別被引用数1970 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 5 件1993 年: 被引用 4 件1994 年: 被引用 8 件1995 年: 被引用 3 件1996 年: 被引用 7 件1997 年: 被引用 10 件1998 年: 被引用 11 件1999 年: 被引用 11 件2000 年: 被引用 21 件2001 年: 被引用 7 件2002 年: 被引用 12 件2003 年: 被引用 20 件2004 年: 被引用 22 件2005 年: 被引用 33 件2006 年: 被引用 50 件2007 年: 被引用 51 件2008 年: 被引用 51 件2009 年: 被引用 40 件2010 年: 被引用 48 件2011 年: 被引用 87 件2012 年: 被引用 144 件2013 年: 被引用 200 件2014 年: 被引用 228 件2015 年: 被引用 249 件2016 年: 被引用 209 件2017 年: 被引用 210 件2018 年: 被引用 264 件2019 年: 被引用 561 件2020 年: 被引用 948 件2021 年: 被引用 1,041 件2022 年: 被引用 1,116 件2023 年: 被引用 870 件2024 年: 被引用 1,469 件2025 年: 被引用 872 件2026 年: 被引用 70 件1971〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,575 件、この内訳の 29.7%アメリカ合衆国: 引用元論文 1,559 件、この内訳の 12.9%インド: 引用元論文 838 件、この内訳の 7%イギリス: 引用元論文 540 件、この内訳の 4.5%イタリア: 引用元論文 320 件、この内訳の 2.7%ドイツ: 引用元論文 305 件、この内訳の 2.5%オーストラリア: 引用元論文 282 件、この内訳の 2.3%韓国: 引用元論文 271 件、この内訳の 2.2%カナダ: 引用元論文 255 件、この内訳の 2.1%台湾: 引用元論文 238 件、この内訳の 2%日本: 引用元論文 235 件、この内訳の 1.9%フランス: 引用元論文 226 件、この内訳の 1.9%
0%29.7%その他 28.3%

機関

分野

  • Medicine33.4%
  • Computer Science27.6%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Engineering7.8%
  • Psychology4.6%
  • Materials Science2.7%
  • その他9.1%

トピック

  • Advanced Authentication Protocols Security3.8%
  • Cryptography and Data Security3.6%
  • Lung Cancer Treatments and Mutations3.1%
  • Cancer Immunotherapy and Biomarkers2.7%
  • User Authentication and Security Systems2.7%
  • Lung Cancer Research Studies1.8%
  • その他82.3%

共著者

全論文

検索で開く
  1. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

    著者: Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan, Lizhu Lin, Kangsheng Gu, Ying Liu, Yi Ba, Zhanhui Miao, Xiaodong Jiang, Ming Zeng, Jianhua Chen, Zhichao Fu, Lu Gan, Jun Wang, Xianbao Zhan, Tianshu Liu, Zhiping Li, Lin Shen, Yongqian Shu, Tao Zhang, Qing Yang, Jianjun Zou, Suxia Luo, Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao - The Lancet Oncology 2020 被引用: 584

  2. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer

    著者: Min Yuan, Lili Huang, Jianhua Chen, Jie Wu, Qing Xu - Signal Transduction and Targeted Therapy 2019 被引用: 703

  3. Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

    著者: Shengxiang Ren, Jianhua Chen, Xingxiang Xu, Tao Jiang, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang, Wenxiu Yao, Rui Wang, Xingya Li, Wei Zhang, Yanjun Zhang, Sheng Hu, Renhua Guo, Jianhua Shi, Zhiwu Wang, Peiguo Cao, Donglin Wang, Jian Fang, Hui Luo, Yi Geng, Chunyan Xing, Dongqing Lv, Yiping Zhang, Junyan Yu, Shundong Cang, Zeyu Yang, Wei Shi, Jianjun Zou, Caicun Zhou - Journal of Thoracic Oncology 2021 被引用: 313

  4. Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

    著者: Caicun Zhou, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Fengying Wu, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, Liping Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Tao Zhang, Wei Shi, Jianjun Zou - The Lancet Respiratory Medicine 2020 被引用: 505

  5. Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

    著者: Lin Shen, Ken Kato, Sung‐Bae Kim, Jaffer A. Ajani, Kuaile Zhao, Zhiyong He, Xinmin Yu, Yongqian Shu, Qi Luo, Jufeng Wang, Zhendong Chen, Zuoxing Niu, Longzhen Zhang, Tienan Yi, Jong‐Mu Sun, Jianhua Chen, Guohua Yu, Chen‐Yuan Lin, Hiroki Hara, Qing Bi, Taroh Satoh, Roberto Pazo-Cid, Hendrick-Tobias Arkenau, Christophe Borg, Florian Lordick, Liyun Li, Ningning Ding, Aiyang Tao, Jingwen Shi, Eric Van Cutsem, for the RATIONALE-302 Investigators - Journal of Clinical Oncology 2022 被引用: 306

  6. AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations

    著者: Shun Lü, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhixiang Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lü, Yanping Hu, Liyan Jiang, Qiming Wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wan-cheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Weng Jie, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Changan Sun, Hongying Wei, Chuan Li, Siraj M. Ali, Vincent A. Miller, Qiong Wu - Journal of Clinical Oncology 2022 被引用: 279

  7. BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency

    著者: Feixia Wang, Yifeng Liu, Fei-Da Ni, Jiani Jin, Yiqing Wu, Yun Huang, Xiaohang Ye, Xilin Shen, Ying Yue, Jianhua Chen, Ruixue Chen, Yanye Zhang, Xiao Sun, Siwen Wang, Xiao Xu, Chuan Chen, Jiansheng Guo, Dan Zhang - Nature Communications 2022 被引用: 169

  8. Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

    著者: Caicun Zhou, Ziping Wang, Yuping Sun, Lejie Cao, Zhiyong Ma, Rong Wu, Yan Yu, Wenxiu Yao, Jianhua Chang, Jianhua Chen, Wu Zhuang, Jiuwei Cui, Xueqin Chen, You Lu, Hong Shen, Jingru Wang, Peiqi Li, Mengmeng Qin, Dongmei Lu, Jason Yang - The Lancet Oncology 2022 被引用: 224

  9. CPP-CLAS: Efficient and Conditional Privacy-Preserving Certificateless Aggregate Signature Scheme for VANETs

    著者: Yulei Chen, Jianhua Chen - IEEE Internet of Things Journal, IEEE Internet Things J. 2021 被引用: 86

  10. AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial

    著者: Yuanyuan Zhao, Gang Chen, Jianhua Chen, Li Zhuang, Yingying Du, Qitao Yu, Wu Zhuang, Yanqiu Zhao, Ming Zhou, Weidong Zhang, Yu Zhang, Yixin Wan, Wenting Li, Weifeng Song, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang - EClinicalMedicine 2023 被引用: 98

  11. Vertical organic electrochemical transistors for complementary circuits

    著者: Wei Huang, Jianhua Chen, Yao Yao, Ding Zheng, Xudong Ji, Liang‐Wen Feng, David C. Moore, Nicholas R. Glavin, Miao Xie, Yao Chen, Robert M. Pankow, Abhijith Surendran, Zhi Wang, Yu Xia, Libing Bai, Jonathan Rivnay, Jianfeng Ping, Xugang Guo, Yuhua Cheng, Tobin J. Marks, Antonio Facchetti - Nature 2023 被引用: 392

  12. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

    著者: Yongyong Shi, Han Zhao, Yuhua Shi, Yunxia Cao, Dongzi Yang, Zhiqiang Li, Bo Zhang, Xiaoyan Liang, Tao Li, Jianhua Chen, Jiawei Shen, Junzhao Zhao, You Li, Xuan Gao, Dongyi Zhu, Xiaoming Zhao, Ying Yan, Yingying Qin, Wenjin Li, Junhao Yan, Qingzhong Wang, Junli Zhao, Ling Geng, Jinlong Ma, Yueran Zhao, Guang He, Aiping Zhang, Shuhua Zou, Aijun Yang, Jiayin Liu, Weidong Li, Baojie Li, Chunling Wan, Ying Qin, Juanzi Shi, Jing Yang, Hong Jiang, Jine Xu, Xiujuan Qi, Yun Sun, Yajie Zhang, Cuifang Hao, Xiuqing Ju, Dongni Zhao, Chune Ren, Xiu‐Qing Li, Wei Zhang, Yiwen Zhang, Jiangtao Zhang, Di Wu, Changming Zhang, Lin He, Zi‐Jiang Chen - Nature Genetics 2012 被引用: 747

  13. Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

    著者: Caicun Zhou, Xingya Li, Qiming Wang, Guanghui Gao, Yiping Zhang, Jianhua Chen, Yongqian Shu, Yanping Hu, Yun Fan, Jian Fang, Gongyan Chen, Jun Zhao, Jianxing He, Fengying Wu, Jianjun Zou, Xiaoyu Zhu, Xiang Lin - Journal of Clinical Oncology 2020 被引用: 206

  14. TSPAN8 + myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer

    著者: Guangjian Fan, Bo Yu, Lei Tang, Rongxuan Zhu, Jianhua Chen, Ying Zhu, He Huang, Liying Zhou, Jun Liu, Wei Wang, Zhonghua Tao, Fengchun Zhang, S. Yu, Xiaoqing Lu, Yuan Cao, Shaoqian Du, Huihui Li, Junjian Li, Jian Zhang, He Ren, Olivier Gires, Hai‐Kun Liu, Xin Wang, Jun Qin, Hongxia Wang - Science Translational Medicine 2024 被引用: 87

  15. Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

    著者: Anwen Xiong, Lei Wang, Jianhua Chen, Lin Wu, Baogang Liu, Jun Yao, Hua Zhong, Jie Li, Ying Cheng, Yulan Sun, Hui Ge, Ji‐Fang Yao, Qin Shi, Ming Zhou, Bolin Chen, Zhengxiang Han, Jinliang Wang, Qing Bu, Yanqiu Zhao, Junqiang Chen, Ligong Nie, Gaofeng Li, Xingya Li, Xinmin Yu, Yinghua Ji, Daqiang Sun, Xiaohong Ai, Qian Chu, Lin Yu, Hao Jiqing, Dingzhi Huang, Chengzhi Zhou, Jinlu Shan, Hongzhong Yang, Xuewen Liu, Jing Wang, Yanhong Shang, Xiaodong Mei, Jie Yang, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Caicun Zhou, Caicun Zhou, Caicun Zhou - The Lancet 2025 被引用: 133

  16. A secure and efficient authentication and data sharing scheme for Internet of Things based on blockchain

    著者: Qing Fan, Jianhua Chen, Lazarus Jegatha Deborah, Min Luo - Journal of Systems Architecture, J. Syst. Archit. 2021 被引用: 73

  17. Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

    著者: Ying Cheng, Jianhua Chen, Wei Zhang, Chao Xie, Qun Hu, Ningning Zhou, Chun Huang, Shihong Wei, Hong Sun, Xingya Li, Yan Yu, Jinhuo Lai, Huaping Yang, Haohui Fang, Hualin Chen, Peng Zhang, Kangsheng Gu, Qiming Wang, Jianhua Shi, Tienan Yi, Xingxiang Xu, Xian-Wei Ye, Daqing Wang, Conghua Xie, Chunling Liu, Yulong Zheng, Daren Lin, Wu Zhuang, Ping Lu, Guohua Yu, Jinzhang Li, Yuhai Gu, Baolan Li, Rong Wu, Ou Jiang, Zaiyi Wang, Guowu Wu, Haifeng Lin, Diansheng Zhong, Yanhua Xu, Yongqian Shu, Di Wu, Xingwu Chen, Jie Wang, Minghui Wang, Runxiang Yang - Nature Medicine 2024 被引用: 121

  18. Robust anonymous authentication protocol for health-care applications using wireless medical sensor networks

    著者: Debiao He, Neeraj Kumar, Jianhua Chen, Cheng-Chi Lee, Naveen K. Chilamkurti, Seng-Soo Yeo - Multimedia Systems, Multim. Syst. 2013 被引用: 327

  19. Certificateless Searchable Public Key Encryption Scheme for Industrial Internet of Things

    著者: Mimi Ma, Debiao He, Neeraj Kumar, Kim-Kwang Raymond Choo, Jianhua Chen - IEEE Transactions on Industrial Informatics, IEEE Trans. Ind. Informatics 2017 被引用: 239

  20. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort

    著者: Kaitlin H. Wade, Brian Lam, Audrey Melvin, Warren W. Pan, Laura J. Corbin, David A. Hughes, Kara Rainbow, Jianhua Chen, Katie Duckett, Xiaoming Liu, Jacek Mokrosiński, Alexander Mörseburg, S Neaves, Alice Williamson, Chen Zhang, I. Sadaf Farooqi, Giles S.H. Yeo, Nicholas J. Timpson, Stephen O’Rahilly - Nature Medicine 2021 被引用: 131

  21. Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia

    著者: Zhiqiang Li, Jianhua Chen, Hao Yu, Lin He, Yifeng Xu, Dai Zhang, Qizhong Yi, Changgui Li, Xingwang Li, Jiawei Shen, Zhijian Song, Weidong Ji, Meng Wang, Juan Zhou, Boyu Chen, Yahui Liu, Jiqiang Wang, Peng Wang, Ping Yang, Qingzhong Wang, Guoyin Feng, Benxiu Liu, Wensheng Sun, Baojie Li, Guang He, Weidong Li, Chunling Wan, Qi Xu, Wenjin Li, Zujia Wen, Ke Liu, Fang Huang, Jue Ji, Stephan Ripke, Weihua Yue, Patrick F. Sullivan, Michael O‘Donovan, Yongyong Shi - Nature Genetics 2017 被引用: 476

  22. Recurrent gain-of-function USP8 mutations in Cushing's disease

    著者: Zengyi Ma, Zhijian Song, Jianhua Chen, Yongfei Wang, Shiqi Li, Liangfu Zhou, Ying Mao, Yiming Li, Ronggui Hu, Zhaoyun Zhang, Hongying Ye, Ming Shen, Xuefei Shou, Zhiqiang Li, Hong Peng, Qingzhong Wang, Daizhan Zhou, Xiaolan Qin, Jue Ji, Jie Zheng, Hong Chen, Yin Wang, Daoying Geng, Wei-Jun Tang, Chaowei Fu, Zhifeng Shi, Yichao Zhang, Zhao Ye, Wenqiang He, Qilin Zhang, Qisheng Tang, Rong Xie, Jiawei Shen, Zujia Wen, Juan Zhou, Tao Wang, Shan Huang, Huijia Qiu, Nidan Qiao, Yi Zhang, Li Pan, Weimin Bao, Yingchao Liu, Chuanxin Huang, Yongyong Shi, Yao Zhao - Cell Research 2015 被引用: 360

  23. Highly stretchable organic electrochemical transistors with strain-resistant performance

    著者: Jianhua Chen, Wei Huang, Ding Zheng, Zhaoqian Xie, Xinming Zhuang, Dan Zhao, Yao Chen, Ning Su, Hongming Chen, Robert M. Pankow, Zhan Gao, Junsheng Yu, Xugang Guo, Yuhua Cheng, Joseph Strzalka, Xinge Yu, Tobin J. Marks, Antonio Facchetti - Nature Materials 2022 被引用: 239

  24. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients

    著者: Gangqin Xi, Wenhui Guo, Deyong Kang, Jianli Ma, Fangmeng Fu, Lida Qiu, Liqin Zheng, Jiajia He, Na Fang, Jianhua Chen, Jingtong Li, Shuangmu Zhuo, Xiaoxia Liao, Haohua Tu, Lianhuang Li, Qingyuan Zhang, Chuan Wang, Stephen A. Boppart, Jianxin Chen - Theranostics 2021 被引用: 127